Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2021 > 04 > 10
Other dates of the month:
- Biden’s budget proposal is ‘the most reckless fiscal policy in the last half-century’: economist
- Ebix Class Action Reminder
- ‘This is the single worst time to be a passive investor’: veteran investor
- EHang Class Action Reminder
- Jianpu Class Action Reminder
- 10 Best Stocks That Will Gain From Biden’s Job and Infrastructure Plan
- Bill Gates Is Right About SPACs and QuantumScape
- How Elon Musk Responded To Competitor Nio's 100,000th Vehicle Milestone
- Finary Raises $3.2M For Platform That Enables Finance Creators To Monetize Content
- Gennao Bio Presents New Data on Novel Gene Monoclonal Antibody Platform Technology at the American Association for Cancer Research (AACR) 2021 Annual Meeting
- Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021
- Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
- Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021
- Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001
- Codiak Presents Data at AACR 2021 Demonstrating Potential of Engineered Exosomes to Enhance the Therapeutic Index of Well-Validated Cancer Immunotherapy Pathways
- Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021
- Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
- Inivata Presents New Data in Support of its Liquid Biopsy Technologies at AACR Virtual Annual Meeting 2021
- Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting
- MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
- Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR
- Achilles Therapeutics Demonstrates cNeT Product Characterization and Post-Infusion Tracking in a Patient Case Study at the American Association for Cancer Research (AACR) 2021 Annual Meeting
- NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021
- NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR) Annual Meeting 2021
- OncXerna Therapeutics Provides New Results from its Xerna™ RNA-based Biomarker Platform at the AACR Annual Meeting
- iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021
- 10 Best Cobalt Stocks To Buy For 2021
- Behold, the Global Small-Cap Renaissance
- Arch Oncology Presents New Preclinical T-ALL Data on Highly-differentiated Anti-CD47 Antibody AO-176 at AACR 2021
- Advaxis Presents Translational Biomarker Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the American Associated for Cancer Research (AACR) 2021 Annual Meeting
- CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function
- HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
- Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
- TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting
- Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting
- Fourth stimulus check: Lawmakers press Biden to say yes to more payments
- New Clinical Responses for AGEN1181 Presented at AACR
- 10 Best High-Yield Dividend Stocks to Buy According to Billionaire George Soros
- Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting
- ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages CytoDyn Inc. Investors to Secure Counsel Before Important May 17 Deadline – CYDY
- WOOF Stock: 3 Reasons To Befriend This Recent IPO
- Ethereum Reaches New All-time High Of $2,200
- Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Ebix, Inc.
- Far-Right Extremist Planned to Blow Up Amazon Data Center, Feds Allege
- Franklin Wireless Stock Gives Every Indication Of Being Fairly Valued
- Heading Into Earnings Season with Dow and S&P at Record Highs
- F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster
- SOS SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Filed Against SOS Limited
- ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Neptune Wellness Solutions Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - NEPT
- ChargePoint Needs a Big Push To Return to Its Former Glory